Concepedia

Aristotelis Bamias

AB

Statistics

Publications

192

Citations

15.8K

H-Index

56

Active since

1990

Affiliations

National and Kapodistrian University of Athens(Current)

Alexandra Hospital

Icahn School of Medicine at Mount Sinai

Fondazione IRCCS Istituto Nazionale dei Tumori

Istituti di Ricovero e Cura a Carattere Scientifico

Aristotelis Bamias is an author at National and Kapodistrian University of Athens specializing in medicine, oncology, and chemotherapy.

ORCID

Publications per year

1990–2025

192

Publications

192

Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial

Éric Pujade-Lauraine, Felix Hilpert, B. Weber et al. · Journal of Clinical Oncology · 2014 · 1.6K citations · Full text

, , +17

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

Thomas Powles, Ignacio Durán, Michiel S. van der Heijden et al. · The Lancet · 2017 · 1.4K citations · Full text

, , +12

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma

Dean F. Bajorin, J. Alfred Witjes, Jürgen E. Gschwend et al. · New England Journal of Medicine · 2021 · 1K citations · Full text

, , +17

Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial

Matthew D. Galsky, Jóse Ángel Arranz Arija, Aristotelis Bamias et al. · The Lancet · 2020 · 787 citations · Full text

, , +13

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

Ronald de Wit, Johann S. de Bono, Cora N. Sternberg et al. · New England Journal of Medicine · 2019 · 660 citations · Full text

, , +17

1–5 of 192